Cardinal Health Expands Home Care Business With Two Acquisitions

CAH is set to buy two home-care businesses for about $360 million, expanding diabetes and urology reach while targeting first-year EPS accretion.

Zacks Investment Research • Jul 22, 2026

Should Value Investors Buy Cardinal Health (CAH) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Investment Research • Jul 22, 2026

Here's Why Cardinal Health (CAH) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Investment Research • Jul 21, 2026

Cardinal Health to buy AdaptHealth diabetes unit, Strive Medical for $360 million

Cardinal Health said on Monday it has agreed to buy AdaptHealth's diabetes health business and ​medical supply provider Strive Medical in separate deals ‌for about $360 million in total, expanding its home care business.

Reuters • Jul 20, 2026

Cardinal Health (CAH) Registers a Bigger Fall Than the Market: Important Facts to Note

Cardinal Health (CAH) reached $225.75 at the closing of the latest trading day, reflecting a -1.21% change compared to its last close.

Zacks Investment Research • Jul 20, 2026

Cardinal Health expands home care business with two tuck-in acquisitions

DUBLIN, Ohio, July 20, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today it has entered into two definitive agreements that accelerate its at-Home Solutions' growth strategy. Cardinal Health will acquire the Diabetes Health business of AdaptHealth Corp. (NASDAQ: AHCO), and, in its entirety, Strive Medical, a multi-specialty supply provider with a focus on urology.

PRNewsWire • Jul 20, 2026

Cardinal Health (CAH) Stock Sinks As Market Gains: Here's Why

In the closing of the recent trading day, Cardinal Health (CAH) stood at $230.11, denoting a -1.52% move from the preceding trading day.

Zacks Investment Research • Jul 14, 2026

Zacks Industry Outlook McKesson, Cardinal, West Pharmaceutical, Align and Henry

McKesson, Cardinal, West Pharmaceutical, Align and Henry have been highlighted in this Industry Outlook article.

Zacks Investment Research • Jul 14, 2026

Why Cardinal (CAH) is Poised to Beat Earnings Estimates Again

Cardinal (CAH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Investment Research • Jul 13, 2026

Here's Why Cardinal Health (CAH) is a Strong Growth Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Investment Research • Jul 13, 2026